Results 251 to 260 of about 4,589,213 (294)
Some of the next articles are maybe not open access.
Crossregulation Between Th1 and Th2 Cells
Critical Reviews™ in Immunology, 1998Th1 and Th2 subsets have been characterized on the basis of the cytokines they secrete and the immune functions they mediate. Th1 cells secrete IL-2, IFN-gamma, and lymphotoxin and are important in the cell-mediated response; Th2 cells secrete IL-4, IL-5, IL-10, and IL-13 and are important in the control of macrophage function and in the stimulation of
P A, Morel, T B, Oriss
openaire +2 more sources
Th2 Cells: Orchestrating Barrier Immunity
2004Publisher Summary This chapter summarizes recent insights regarding the generation of T helper (Th) 2 cells and factors regulating expression of IL-4—the canonical cytokine secreted by these cells. Th2 cells orchestrate a stereotyped cell response characterized by eosinophil and basophil infiltration, mast cell hyperplasia, and changes in epithelial ...
Daniel B, Stetson +7 more
openaire +2 more sources
Biology of human TH1 and TH2 cells
Journal of Clinical Immunology, 1995Evidence is accumulating to suggest the existence of polarized human T-cell responses, reminiscent of TH1 and TH2 subsets described for mouse T cells. Human TH1 cells preferentially develop during infections by intracellular bacteria and trigger phagocyte-mediated host defense, whereas TH2 cells, which predominate during helminthic infestations and in ...
openaire +2 more sources
Targeting Th2 Cells in Asthmatic Airways
2010Asthma represents a profound worldwide public health problem. The most effective anti-asthmatic drugs currently available include inhaled β2 -agonists and glucocorti-coids; these control asthma in about 90–95% of patients. However, the future therapies will need to focus on the 5–10% patients who do not respond well to these treatments and who account ...
CARAMORI, Gaetano +5 more
openaire +1 more source
Targeting Th2 cells in asthmatic patients.
2004The most effective anti-asthmatic drugs currently available include inhaled beta2-agonists and glucocorticoids and control asthma in about 95% of patients. The current asthma therapies are not cures and symptoms return soon after the treatment is stopped even after long-term therapy.
CARAMORI, Gaetano, ITO K, ADCOCK IM
openaire +3 more sources
Dopamine primes TH2 cells in the lungs
Journal of Allergy and Clinical Immunology, 2023Derek J, Bangs, Marion, Pepper
openaire +2 more sources
New advances on human TH1 and TH2 cells
1994HUMAN TH1 AND TH2 ...
ROMAGNANI, SERGIO +12 more
openaire +3 more sources